Definitive Contract 75F40122C00087
Award Date 7/13/22
Potential Completion Date 1/14/28
Potential Value $502K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Providence, RI 02908, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a $273,313.94 firm fixed price contract to the Rhode Island Department of Health to conduct inspections of mammography facilities in the state of Rhode Island. This contract, which does not have a set-aside designation, runs from September 15, 2017 through June 30, 2022. The Rhode Island Department of Health is a state government entity that provides public health services, including managing programs related to...
- This is a definitive contract awarded by the Food and Drug Administration (FDA) to the Rhode Island Department of Health, a U.S. state government entity. The $57,398.72 firm fixed price contract is for miscellaneous testing services. As the prime contractor, the Rhode Island Department of Health, through its Environmental Health Division, has expertise in conducting inspections, testing, and safety consultations related to public health programs such as mammography quality, infectious disease...
- This $1,177,784.02 firm fixed-price federal contract was awarded by the Food and Drug Administration (FDA) to the Washington State Department of Health to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of July 21, 2027. This sole source contract was awarded without a set-aside. The Washington State Department of Health, as a state...
- The U.S. Food and Drug Administration awarded a firm fixed-price purchase order valued at $30,321.90 to the Washington State Department of Health for Mammography Quality Standards Act (MQSA) inspections. The contract was awarded on March 29, 2004, with an ultimate completion date of April 1, 2005, and performed in Tumwater, Washington. No set-aside designation was used for this procurement. The Washington State Department of Health, a state government agency specializing in public health...
- The U.S. Food and Drug Administration (FDA) awarded a $262,548.81 firm fixed-price contract to the South Dakota Department of Health (SD DOH) to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). This contract, awarded on June 30, 2022, has an ultimate completion date of January 1, 2028. The contract was issued as a sole-source award, as the state government organization is the...
- This is a $2,685,565.01 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Department of Public Health (MDPH) for Massachusetts MQSA (Mammography Quality Standards Act) new contract services. The contract has no set-aside designation and an ultimate completion date of January 21, 2028. MDPH, a U.S. state government agency, is the prime contractor and will provide specialized public health services to the FDA, including food and tobacco...
- This is a sole-source federal contract awarded by the Food and Drug Administration (FDA) to the State of North Carolina Department of Health & Human Services (NC DHHS) to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has a ceiling value of $2,548,801.45 and a period of performance ending on September 29, 2027. This is a Firm Fixed Price contract with no...
- This is a $370,094.84 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA) to the State of Utah Department of Environmental Quality (UDEQ) to conduct inspections of certified non-federal mammography facilities. The contract supports the Mammography Quality Standards Act (MQSA) program, which requires regular inspections to ensure compliance with quality standards. As a state government agency, UDEQ has the legal authority and experienced personnel necessary to...
- The Food and Drug Administration (FDA) awarded a $485,906.49 firm fixed-price contract to the Arkansas Department of Health (ADH) to conduct inspections of certified non-federal mammography facilities in Arkansas. This contract, awarded on August 8, 2022, is part of the Mammography Quality Standards Act (MQSA) and runs through August 1, 2027. The contract was awarded as a sole source award, as ADH is the only organization in Arkansas with the legal authority and experience required to perform...
- This is a $156,785.01 firm-fixed-price definitive contract between the Food and Drug Administration (FDA) and the Puerto Rico Department of Health (PRDOH) for mammography quality standards inspections (MQSA). The contract runs from July 14, 2017 to July 13, 2022, with no set-aside designation. PRDOH, the primary government agency responsible for public health in Puerto Rico, is the prime contractor for this contract. This award is not associated with a larger contract vehicle. The contract...